Stock Events

Stock Events

Kane Biotech 

$0.016650
5
+$0.00+0% Friday 19:21

Statistics

Day High
0.019
Day Low
0.0185
52W High
0.0338
52W Low
0.01038
Volume
50,000
Avg. Volume
138,239
Mkt Cap
3.03M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

24NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0064

Financials

-650.7%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
296,852.19Revenue
-1.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KNBIF. It's not an investment recommendation.
Enbridge
2
ENB.TO
ExxonMobil
2
XOM
Energy Transfer
2
ET
Suncor Energy
2
SU.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. develops and produces medicines and vaccines for a wide range of medical disciplines, including biotherapeutics for wound healing, which competes with Kane Biotech's biofilm products.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the research and development of biopharmaceutical products, directly competing in the wound care market where Kane Biotech is also active.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in the healthcare sector focusing on medical devices, diagnostics, and nutritional products that overlap with Kane Biotech's therapeutic areas.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. provides healthcare solutions including anti-infective agents and wound care treatments that compete with Kane Biotech's antimicrobial technologies.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. focuses on human therapeutics, including treatments in inflammation that compete with Kane Biotech's anti-biofilm products used in various medical applications.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. develops and markets drugs in areas such as infectious disease, which competes with Kane Biotech's focus on biofilm-preventive healthcare solutions.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is involved in biopharmaceutical products targeting inflammatory conditions, directly competing with Kane's biofilm technology in medical treatments.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company offers biopharmaceutical products, including those for wound healing and infection prevention, areas where Kane Biotech also operates.
Novartis
NVS
Mkt Cap292.35B
Novartis AG focuses on innovative healthcare solutions including advanced wound care, competing in the same space as Kane Biotech's biofilm-targeting products.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company develops pharmaceutical products that address chronic conditions, overlapping with Kane Biotech's focus on chronic wound infections and care.

About

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections. Its wound care product portfolio includes antimicrobial wound gel, antimicrobial wound gel spray, and antimicrobial wound rinse under revyve name, as well as antimicrobial surgical hydrogel under coactiv+ name. In addition, the company offers scalp detoxifier product line under the Omni Bioceuticals brand. Further, it engages in developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; revyve Antimicrobial Wound Rinse for use in acute and chronic wounds; DispersinB Hydrogel for use in surgical/acute wounds; and DispersinB Acne Cleanser for use in the treatment of mild to moderate acne vulgaris. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Show more...
CEO
Robert Huizinga
Employees
20
Country
Canada
ISIN
CA4838092084

Listings

OTC Link
US
KNBIF
V
CA
KNE.V

0 Comments

Share your thoughts

FAQ

What is Kane Biotech stock price today?▼
The current price of KNBIF is $0.02 USD — it has increased by +0% in the past 24 hours. Watch Kane Biotech stock price performance more closely on the chart.
What is Kane Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kane Biotech stocks are traded under the ticker KNBIF.
Is Kane Biotech stock price growing?▼
KNBIF stock has fallen by -10% compared to the previous week, the month change is a -4.31% fall, over the last year Kane Biotech has showed a -46.29% decrease.
What is Kane Biotech market cap?▼
Today Kane Biotech has the market capitalization of 3.03M
What were Kane Biotech earnings last quarter?▼
KNBIF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kane Biotech revenue for the last year?▼
Kane Biotech revenue for the last year amounts to 296,852.19 USD.
What is Kane Biotech net income for the last year?▼
KNBIF net income for the last year is -1.93M USD.
How many employees does Kane Biotech have?▼
As of September 05, 2026, the company has 20 employees.
In which sector is Kane Biotech located?▼
Kane Biotech operates in the Health & Wellness sector.
When did Kane Biotech complete a stock split?▼
The last stock split for Kane Biotech was on March 13, 2017 with a ratio of 1:5.
Where is Kane Biotech headquartered?▼
Kane Biotech is headquartered in Winnipeg, Canada.